Advisory: Evidence-Based, Whole-Person Care for Pregnant People Who Have Opioid Use Disorder (DA2304)
Author(s): Substance Abuse and Mental Health Services Administration
Pre-Approved for: CA BRN, CCAPP, CE Broker Provider, Delaware BON, FCB, MCBAP-Specific , NAADAC, RNs
Credit Hours: 2
This course is online. All course material is available online and is accessible immediately after purchase from your account homepage. Certificate of Completion is available immediately upon passing the exam.
This Substance Abuse and Mental Health Services Administration (SAMHSA) Advisory outlines how healthcare providers can take an active role in supporting the health of pregnant people who have opioid use disorder (OUD) as well as their babies. This course offers healthcare providers an opportunity to end the opioid crisis and with help, more pregnant people can learn about their options for treatment and recovery for better health outcomes.
- Recognize the need for providers to prioritize health equity for underserved pregnant people with OUD in critical requirements of culturally responsive and empathetic care.
- Identify the needs of the pregnant person using "whole-patient" care approaches such as assessment and treatment plans for co-occurring mental disorders in pregnant patients with OUD.
- Educate other healthcare professionals and pregnant people about options for treatment, filling the treatment gap, and the benefits of recovery.
- Optimize a better health outcomes approach by offering universal prenatal SUD screening, prescribing pharmacological treatment if appropriate, and connecting pregnant people with other harm reduction services.
- Follow up and evaluate client progress to maximize the recovery process and to strive for delivering better care services.
- Key Messages
- Providers Can Fill the Treatment Gap for Pregnant People With OUD
- Exhibit 1: Changes in the Cumulative Number of Buprenorphine-Waivered Providers From 2018 to 2021 (OB-GYNs and Certified Nurse Midwives)
- Exhibit 2: Pregnant People Served Through SAMHSA's Substance Use Prevention, Treatment, and Recovery Services
- A Call to Action
- Resource Alert: Harm Reduction Services to Support Pregnant People With OUD
- Screening and Assessment to Support the Treatment of OUD in Pregnant People
- Initiating Pharmacotherapy for OUD
- Key Differences Between Medications to Treat OUD During Pregnancy
- Guidance for Providers About OUD Medication Use During Pregnancy
- Managing Pharmacotherapy Over the Course of Pregnancy
- Providing Comprehensive Patient-Centered Care for Pregnant People Who Have OUD: Treating the Whole Person